Open AccessExpert Panel Discussion
The ASCOT Trial—Are β‐Blockers Still Useful as Antihypertensive Medication?
Author(s) -
Moser Marvin,
Giles Thomas D.,
Pickering Thomas G.,
Victor Ronald G.
Publication year - 2006
Publication title -
the journal of clinical hypertension
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.909
H-Index - 67
eISSN - 1751-7176
pISSN - 1524-6175
DOI - 10.1111/j.1524-6175.2006.05659.x
Subject(s) - medicine , panel discussion , haven , columbia university , family medicine , medical school , gerontology , medical education , media studies , mathematics , combinatorics , sociology , advertising , business
Following a hypertension symposium in New York, NY in March 2006, an expert panel was convened to discuss the Anglo‐Scandinavian Cardiac Outcomes Trial (ASCOT) and the future of β‐blocker therapy. Dr Marvin Moser of the Yale University School of Medicine, New Haven, CT chaired the panel, which included Dr Thomas D. Giles, President of the American Society of Hypertension and Professor of Medicine at Louisiana State University School of Medicine, New Orleans, LA; Dr Thomas G. Pickering, Director of Behavioral Cardiovascular Health at Columbia University College of Physicians and Surgeons, New York, NY; and Dr Ronald G. Victor, Professor of Internal Medicine and Division Chief of Hypertension at the University of Texas Southwestern Medical Center, Dallas, TX.